Literature DB >> 9887327

EYA4, a novel vertebrate gene related to Drosophila eyes absent.

G Borsani1, A DeGrandi, A Ballabio, A Bulfone, L Bernard, S Banfi, C Gattuso, M Mariani, M Dixon, D Donnai, K Metcalfe, R Winter, M Robertson, R Axton, A Brown, V van Heyningen, I Hanson.   

Abstract

We have isolated a family of four vertebrate genes homologous to eyes absent (eya), a key regulator of ocular development in Drosophila. Here we present the detailed characterization of the EYA4 gene in human and mouse. EYA4 encodes a 640 amino acid protein containing a highly conserved C-terminal domain of 271 amino acids which in Drosophila eya is known to mediate developmentally important protein-protein interactions. Human EYA4 maps to 6q23 and mouse Eya4 maps to the predicted homology region near the centromere of chromosome 10. In the developing mouse embryo, Eya4 is expressed primarily in the craniofacial mesenchyme, the dermamyotome and the limb. On the basis of map position and expression pattern, EYA4 is a candidate for oculo-dento-digital (ODD) syndrome, but no EYA4 mutations were found in a panel of ODD patients.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9887327     DOI: 10.1093/hmg/8.1.11

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  45 in total

1.  Synergistic regulation of vertebrate muscle development by Dach2, Eya2, and Six1, homologs of genes required for Drosophila eye formation.

Authors:  T A Heanue; R Reshef; R J Davis; G Mardon; G Oliver; S Tomarev; A B Lassar; C J Tabin
Journal:  Genes Dev       Date:  1999-12-15       Impact factor: 11.361

2.  Molecular analysis of Drosophila eyes absent mutants reveals features of the conserved Eya domain.

Authors:  Q T Bui; J E Zimmerman; H Liu; N M Bonini
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

Review 3.  Molecular conservation and novelties in vertebrate ear development.

Authors:  B Fritzsch; K W Beisel
Journal:  Curr Top Dev Biol       Date:  2003       Impact factor: 4.897

4.  Six and Eya expression during human somitogenesis and MyoD gene family activation.

Authors:  Françoise Fougerousse; Muriel Durand; Soledad Lopez; Laurence Suel; Josiane Demignon; Charles Thornton; Hidenori Ozaki; Kyoshi Kawakami; Patrick Barbet; Jacques S Beckmann; Pascal Maire
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

5.  Six1 and Eya1 expression can reprogram adult muscle from the slow-twitch phenotype into the fast-twitch phenotype.

Authors:  Raphaelle Grifone; Christine Laclef; François Spitz; Soledad Lopez; Josiane Demignon; Jacques-Emmanuel Guidotti; Kiyoshi Kawakami; Pin-Xian Xu; Robert Kelly; Basil J Petrof; Dominique Daegelen; Jean-Paul Concordet; Pascal Maire
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

6.  EWS/FLI1 regulates EYA3 in Ewing sarcoma via modulation of miRNA-708, resulting in increased cell survival and chemoresistance.

Authors:  Tyler P Robin; Anna Smith; Erin McKinsey; Lisa Reaves; Paul Jedlicka; Heide L Ford
Journal:  Mol Cancer Res       Date:  2012-06-20       Impact factor: 5.852

Review 7.  Multiple Functions of the Eya Phosphotyrosine Phosphatase.

Authors:  Ilaria Rebay
Journal:  Mol Cell Biol       Date:  2015-12-14       Impact factor: 4.272

8.  Eya1 and Six1 are essential for early steps of sensory neurogenesis in mammalian cranial placodes.

Authors:  Dan Zou; Derek Silvius; Bernd Fritzsch; Pin-Xian Xu
Journal:  Development       Date:  2004-10-20       Impact factor: 6.868

9.  Regulation of the innate immune response by threonine-phosphatase of Eyes absent.

Authors:  Yasutaka Okabe; Teruyuki Sano; Shigekazu Nagata
Journal:  Nature       Date:  2009-06-28       Impact factor: 49.962

Review 10.  Relationship between the expression of hTERT and EYA4 mRNA in peripheral blood mononuclear cells with the progressive stages of carcinogenesis of the esophagus.

Authors:  Hao Li; Tao Yu Diao; Zhi Ying Zhou; Fang Yan Yang; Qing Ma; Qing Hui Li
Journal:  J Exp Clin Cancer Res       Date:  2009-11-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.